ANTITUMORVERBINDUNGEN

European patent · EP4047002 · In force

Register entry

Publication number
EP4047002
Application number
EP22166571
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 27, 2018
Published
Aug 24, 2022
Granted
Mar 8, 2023
Protection ends at the latest
Apr 26, 2038
Next annual fee due
Apr 30, 2027
IPC classes
C07D 515/22 (2006.01)
A61P 35/00 (2006.01)
A61K 31/4995 (2006.01)
Priority
EP 17382228 27.04.2017
EP 17382497 26.07.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. Jan 17, 2024

    Change

    Published in Swissreg on 17.01.2024

  5. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  6. Apr 27, 2023

    Agent entered

    Representative
    Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg

    Published in Swissreg on 27.04.2023

  7. Mar 8, 2023

    Granted

    Published in Swissreg on 08.03.2023

Parties

Holder

PHARMA MAR, S.A.

Pharma Mar, S.A.

Polígono Industrial La Mina Avda. de los Reyes, 1 Colmenar Viejo, 28770 Madrid, ES

Agent

Servopatent GmbH

Bühlstrasse 1, 8125 Zollikerberg

Inventor

CUEVAS MARCHANTE, Maria del Carmen

28770 Madrid, ES

MARTINEZ BARRASA, Valentin

28770 Colmenar Viejo, ES

FRANCESCH SOLLOSO, Andrés

28770 Madrid, ES

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.